Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Rayneisha Watson"'
Autor:
Jeanne M. Regnante, Nicole Richie, Lola Fashoyin-Aje, Laura Lee Hall, Quita Highsmith, J'Aimee Louis, Kenneth Turner, Spencer Hoover, Simon Craddock Lee, Evelyn González, Erin Williams, Homer Adams, III, Coleman Obasaju, Ify Sargeant, Jovonni Spinner, Christopher Reddick, Marianne Gandee, Madeline Geday, Julie Dang, Rayneisha Watson, Moon S. Chen, Jr.
Publikováno v:
Contemporary Clinical Trials Communications, Vol 17, Iss , Pp - (2020)
Background: Study populations in clinical research must reflect US changing demographics, especially with the rise of precision medicine. However, racial and ethnic minority groups (REMGs) have low rates of participation in cancer clinical trials. Me
Externí odkaz:
https://doaj.org/article/bcf3080c37f64eaa96be3f2b6b05c407
Autor:
Moon S. Chen, Ify Sargeant, Marianne Gandee, Nicole Richie, Julie H.T. Dang, Christopher Reddick, J'Aimee A. Louis, Homer Adams, Jovonni Spinner, Kenneth Turner, Rayneisha Watson, Quita Highsmith, Coleman K. Obasaju, Madeline Geday, Evelyn Gonzalez, Lola Fashoyin-Aje, Spencer C. Hoover, Jeanne M. Regnante, Simon J. Craddock Lee, Laura Lee Hall, Erin Fenske Williams
Publikováno v:
Contemporary Clinical Trials Communications
Contemporary Clinical Trials Communications, Vol 17, Iss, Pp-(2020)
Contemporary Clinical Trials Communications, Vol 17, Iss, Pp-(2020)
Background: Study populations in clinical research must reflect US changing demographics, especially with the rise of precision medicine. However, racial and ethnic minority groups (REMGs) have low rates of participation in cancer clinical trials. Me
Autor:
Ify Sargeant, Simon J. Craddock Lee, Homer Adams, Spencer C. Hoover, Rayneisha Watson, Jeanne M. Regnante, Moon S. Chen, Coleman K. Obasaju, Nicole Richie, Marianne Gandee, Kenneth Turner, Lola Fashoyin-Aje, J'Aimee A. Louis, Madeline Geday, Quita Highsmith, Erin L Williams, Laura Lee Hall
Publikováno v:
Cancer Research. 79:LB-012
Background: Racial and ethnic minority groups (REMGs) have low rates of inclusion in cancer trials. With the rise of precision medicine, it is critical that study populations in clinical research reflect the changing US demographics. Methods: Criteri
Identification of five novel modifier loci of ApcMin harbored in the BXH14 recombinant inbred strain
Autor:
Julie Innocent, Rayneisha Watson, Stephanie C. Nnadi, Arthur M. Buchberg, Gregory E. Gonye, Linda D. Siracusa
Publikováno v:
Carcinogenesis. 33:1589-1597
Every year thousands of people in the USA are diagnosed with small intestine and colorectal cancers (CRC). Although environmental factors affect disease etiology, uncovering underlying genetic factors is imperative for risk assessment and developing